Advancing Digital Measures From Scientific Rigor To Real-World Impact

The transition from experimental digital tools to validated clinical endpoints marks a pivotal shift in how we capture and interpret patient outcomes. This presentation explore how, as digital health technologies (DHTs) expand, the priority has shifted from raw data collection to ensuring these measurements meet rigorous regulatory standards. Key insights from current industry discourse emphasize that the path to widespread adoption relies on aligning digital metrics with the specific expectations of global health authorities. By examining real-world applications across therapeutic areas—including mobility, sleep, and symptom detection—researchers are uncovering how to transform continuous sensor data into robust evidence capable of supporting primary clinical endpoints. Artificial intelligence plays a crucial role here, refining measurement accuracy and identifying subtle adverse events that traditional methods might overlook. Ultimately, the future of digital measurement depends on pre-competitive collaboration and a commitment to standardized frameworks. Moving beyond early-stage exploration toward validated, data-driven decisions allows for a more objective, continuous understanding of the patient experience, ensuring that innovation translates into meaningful clinical progress.